We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 49 start-ups with an aggregate funding of $3.1b. The average funding per company in this subset is $62.3m.
Last update to the database: Feb 18, 2025. See changelog.
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
Spire is a company developing tags that provide health tracking including respiration, sleep, stress, activity, and pulse rate.
5
Funding Rounds
$48.1m
Money raised
miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
3
Funding Rounds
$32.0m
Money raised
Eko Health is a digital health and AI technology company developing tools for heart and lung disease detection.
7
Funding Rounds
$249.0m
Money raised
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
1
Funding Rounds
$5.5m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
3
Funding Rounds
$105.0m
Money raised
AliveCor is a San Francisco-based company developing AI-based ECG technologies.
6
Funding Rounds
$117.7m
Money raised
Moving Analytics is developing a virtual care management software for cardiac rehab.
3
Funding Rounds
$26.9m
Money raised
By applying the latest research in Artificial intelligence, Cardiologs provides a web solution to streamline this process at large scale, enabling the highest diagnostic yield, for the least physician effort.
5
Funding Rounds
$23.2m
Money raised
MyoKardia is a company developing targeted therapies for cardiocavscular diseases founded in 2012 by Leslie Leinwand.
6
Funding Rounds
$98.0m
Money raised
Hello Heart is a company founded in 2013 by Ziv Meltzer.
5
Funding Rounds
$151.0m
Money raised
A cardiovascular genomic diagnostics company that provides clinicians information to improve patient care
4
Funding Rounds
$144.0m
Money raised
NeuroTronik is a company that develops neurostimulation therapeutic devices which are designed to treat acute heart failure syndrome.
1
Funding Rounds
$23.1m
Money raised
Implicity developed a universal remote monitoring platform for cardiac patients with connected pacemakers and implantable defibrillators.
3
Funding Rounds
$54.5m
Money raised
Heartbeat is an experience created to screen, diagnose, track and manage cardiovascular risk and disease to keep you at your healthiest.
2
Funding Rounds
$28.2m
Money raised
Ultromics is an artificial Intelligence company founded in 2017 by Paul Leeson.
3
Funding Rounds
$66.0m
Money raised
VoxelCloud provides automated medical image analysis services and diagnosis assistance based on AI and cloud computing technologies.
6
Funding Rounds
$93.5m
Money raised
Products to detect heart problems at an early stage to prevent heart diseases.
2
Funding Rounds
$22.3m
Money raised
GenesisCare is a company founded in 2001.
1
Funding Rounds
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
2
Funding Rounds
$91.7m
Money raised
Avinger is a Redwood City, California-based medical device company that designs, manufactures, and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD).
3
Funding Rounds
$80.5m
Money raised
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
2
Funding Rounds
$8.2m
Money raised
NewAmsterdam Pharma is a company focusing on the treatment of cardio-metabolic diseases.
1
Funding Rounds
$196.0m
Money raised
InCarda Therapeutics is a company developing therapies for cardiovascular diseases founded in 2009 by Carlos A. Schuler.
2
Funding Rounds
$72.1m
Money raised
Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.
2
Funding Rounds
$235.0m
Money raised
Cardiomatics uses artificial intelligence for electrocardiogram (ECG) reading automation technology.
1
Funding Rounds
$3.5m
Money raised
XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
2
Funding Rounds
$58.9m
Money raised
A technology company offering research and development services focused on cardiovascular disease.
1
Funding Rounds
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
2
Funding Rounds
$167.0m
Money raised
Heart Health Intelligence creates heart data collecting toilet seat, reducing the cost of heart failure through seamless in-home monitoring.
2
Funding Rounds
$44.0m
Money raised
Automated External Defibrillator
2
Funding Rounds
$29.0m
Money raised
Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.
1
Funding Rounds
$16.0m
Money raised
Orchestra BioMed Inc is a medical devices founded in 2017 by David P. Hochman.
2
Funding Rounds
$75.0m
Money raised
Sensible Medical Innovations is a lung Fluid Measurement for Heart Failure Patients founded in 2007 by Amir Ronen, Amir Saroka, Dan Rappaport, Nadav Mizrahi and Shlomi Bergida.
1
Funding Rounds
$20.0m
Money raised
Small Molecules based on Omega-3 Fatty acid metabolites
3
Funding Rounds
$34.9m
Money raised
Bardy Diagnostics, Inc. is a Charlotte, North Carolina-based diagnostic tools company founded in 1985.
1
Funding Rounds
$35.5m
Money raised
Bloomer Tech is a Cambridge, Massachusetts-based company.
1
Funding Rounds
$3.0m
Money raised
Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.
2
Funding Rounds
$3.0m
Money raised
4C Medical Technologies, Inc. is a company founded in 2015.
7
Funding Rounds
$168.0m
Money raised
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
3
Funding Rounds
$19.0m
Money raised
Saranas is a blood vessel access device founded in 2013.
4
Funding Rounds
$19.7m
Money raised
Vector is a cardiac digital health provider that makes it simple for care teams to capture, manage, analyze, and act on remote cardiac data.
1
Funding Rounds
$12.5m
Money raised
Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failure
2
Funding Rounds
$63.0m
Money raised
AUM Cardiovascular is a Northfield, Minnesota-based medical diagnostics company developing medical devices for diagnostics.
4
Funding Rounds
$9.6m
Money raised
Murj is a United States-based company.
2
Funding Rounds
$13.0m
Money raised
To treat Aortic Stenosis, Cardiawave has developed a non-invasive, real-time image-guided medical device using a cutting-edge ultrasound technology, known as Pulsed Cavitational Ultrasound Therapy (PCUT).
1
Funding Rounds
$8.2m
Money raised
HeartLab is transforming cardiology with artificial intelligence.
1
Funding Rounds
$2.5m
Money raised
Company
1
Funding Rounds
$30.0m
Money raised
DiA is an Israel-based company founded by Hila Goldman-Aslan.
2
Funding Rounds
$19.0m
Money raised